Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative phase II study of irosustat in postmenopausal women with estrogen receptor-positive early breast cancer
2011-005240-10Phase 2Terminated
- Sponsor
- Imperial College London
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irosustat in breast cancer, estrogen receptor-positive breast cancer, sponsored by Imperial College London. Started Feb 2012; status: terminated.
02
Drugs
irosustat
03
Conditions
breast cancerestrogen receptor-positive breast cancer
Beyond the preview
Go deeper on 2011-005240-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005240-10.